# Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

> **NCT00182117** · — · UNKNOWN · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 490 (—)

## Conditions studied

- Bleeding
- End Stage Renal Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00182117
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 490 (—)
- **Last updated:** 2006-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00182117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00182117, "Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00182117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
